---
title: "Mirtazapine - Major Depressive Disorder"
sidebar: mydoc_sidebar
permalink: db00370-mesh-d003865-1.html
toc: false 
---


Path ID: `DB00370_MESH_D003865_1`
{% include image.html url="images/db00370-mesh-d003865-1.png" file="db00370-mesh-d003865-1.png" alt="db00370-mesh-d003865-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C035133">MESH:C035133 </a> | Mirtazapine | Drug |
| <a href="https://identifiers.org/UniProt:P28223">UniProt:P28223 </a> | 5-hydroxytryptamine receptor 2A | Protein |
| <a href="https://identifiers.org/UniProt:P28335">UniProt:P28335 </a> | 5-hydroxytryptamine receptor 2C | Protein |
| <a href="https://identifiers.org/UniProt:Q9UE69">UniProt:Q9UE69 </a> | 5HT3 serotonin receptor | Protein |
| <a href="https://identifiers.org/UniProt:P08913">UniProt:P08913 </a> | Alpha-2A adrenergic receptor | Protein |
| <a href="https://identifiers.org/MESH:D012701">MESH:D012701 </a> | Serotonin | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0032099">GO:0032099 </a> | Negative regulation of appetite | BiologicalProcess |
| <a href="https://identifiers.org/HP:0000739">HP:0000739 </a> | Anxiety | PhenotypicFeature |
| <a href="https://identifiers.org/HP:0002360">HP:0002360 </a> | Sleep disturbance | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D003865">MESH:D003865 </a> | Major depressive disorder | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Mirtazapine | DECREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 2A |
| Mirtazapine | DECREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 2C |
| Mirtazapine | DECREASES ACTIVITY OF | 5Ht3 Serotonin Receptor |
| Mirtazapine | DECREASES ACTIVITY OF | Alpha-2A Adrenergic Receptor |
| 5-Hydroxytryptamine Receptor 2A | POSITIVELY CORRELATED WITH | Serotonin |
| 5-Hydroxytryptamine Receptor 2C | POSITIVELY CORRELATED WITH | Serotonin |
| 5Ht3 Serotonin Receptor | POSITIVELY CORRELATED WITH | Serotonin |
| Alpha-2A Adrenergic Receptor | POSITIVELY CORRELATED WITH | Serotonin |
| Serotonin | POSITIVELY CORRELATED WITH | Negative Regulation Of Appetite |
| Serotonin | POSITIVELY CORRELATED WITH | Anxiety |
| Serotonin | POSITIVELY CORRELATED WITH | Sleep Disturbance |
| Negative Regulation Of Appetite | POSITIVELY CORRELATED WITH | Major Depressive Disorder |
| Anxiety | POSITIVELY CORRELATED WITH | Major Depressive Disorder |
| Sleep Disturbance | POSITIVELY CORRELATED WITH | Major Depressive Disorder |
|---------|-----------|---------|

Comment: The (S)-(+) enantiomer of mirtazapine is responsible for antagonism of the serotonin 5-HT2A and 5-HT2C receptors, while the (R)-(â€“) enantiomer is responsible for antagonism of the 5-HT3 receptor.

Reference: 
  - [https://go.drugbank.com/drugs/DB00370#BE0005582](https://go.drugbank.com/drugs/DB00370#BE0005582)
  - [https://en.wikipedia.org/wiki/Mirtazapine#Pharmacology](https://en.wikipedia.org/wiki/Mirtazapine#Pharmacology)
